You can check out the annual or quarterly balance sheets of Mereo BioPharma Group PLC here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023H1

FY2022H2

FY2022H1

FY2021H2

FY2021H1

FY2020H2

FY2020H1

FY2019H2

FY2019H1

FY2018H2

FY2018H1

FY2017H2

FY2017H1

FY2016H2

FY2016H1

Total equity

Cash, cash equivalents and short-term investments

-42.03%36.22M

-41.27%40.99M

-39.52%48.70M

-35.81%56.13M

28.41%62.48M

21.56%69.80M

--80.52M

--87.43M

--48.66M

--57.42M

-42.49%53.50M

-46.58%68.15M

-38.88%93.03M

297.56%127.57M

116.07%152.23M

48.05%32.09M

53.68%70.45M

-38.31%21.67M

-5.96%45.84M

-50.51%35.14M

-33.84%48.75M

7.42%71.00M

-21.08%73.69M

--66.09M

--93.38M

- Cash and cash equivalents

-42.03%36.22M

-41.27%40.99M

-39.52%48.70M

-35.81%56.13M

28.41%62.48M

21.56%69.80M

--80.52M

--87.43M

--48.66M

--57.42M

-42.49%53.50M

-46.58%68.15M

-38.88%93.03M

297.56%127.57M

116.07%152.23M

48.05%32.09M

96.20%70.45M

-32.15%21.67M

-20.99%35.91M

-52.76%31.95M

-32.99%45.45M

2.31%67.62M

-27.36%67.83M

--66.09M

--93.38M

-Short-term investments

----

-100.00%0.00

200.93%9.94M

-5.59%3.19M

-43.67%3.30M

--3.38M

--5.86M

----

Receivables

126.65%2.33M

--3.11M

72.70%2.80M

43.99%3.25M

104.78%1.03M

----

--1.62M

--2.25M

--502.00K

--2.55M

322.86%13.64M

7.23%3.23M

-59.92%3.23M

-52.47%3.01M

-23.26%8.05M

-60.07%6.34M

-14.79%10.49M

111.48%15.88M

-16.04%12.31M

-35.84%7.51M

123.76%14.66M

55.57%11.70M

28.53%6.55M

--7.52M

--5.10M

-Other receivables

281.97%2.01M

--2.62M

98.43%2.28M

71.72%2.75M

--527.00K

----

--1.15M

--1.60M

--0.00

--1.95M

715.45%10.03M

-51.98%921.79K

-13.66%1.23M

38.20%1.92M

-37.44%1.42M

83.17%1.39M

-8.21%2.28M

-2.36%758.42K

221.09%2.48M

12.86%776.77K

22.22%772.38K

-27.26%688.24K

-33.46%631.94K

--946.18K

--949.77K

Prepaid expenses

-8.10%1.02M

-82.39%383.00K

-70.74%519.00K

-6.37%1.65M

-50.38%1.11M

9.19%2.17M

--1.77M

--1.76M

--2.24M

--1.99M

-47.62%1.75M

-0.17%3.78M

-45.40%3.34M

71.06%3.79M

252.08%6.11M

-20.91%2.21M

-55.43%1.74M

105.64%2.80M

140.58%3.89M

-48.89%1.36M

-41.88%1.62M

95.86%2.66M

179.33%2.79M

--1.36M

--997.12K

Other current assets

-79.80%460.00K

-80.76%536.00K

-85.97%394.00K

-83.89%402.00K

8.69%2.28M

54.95%2.79M

--2.81M

--2.50M

--2.10M

--1.80M

----

Total current assets

-40.16%40.03M

-39.78%45.02M

-39.57%52.41M

-34.62%61.42M

25.05%66.90M

17.26%74.76M

--86.72M

--93.94M

--53.50M

--63.76M

-30.83%68.89M

-44.07%75.16M

-40.14%99.60M

230.61%134.37M

101.25%166.39M

0.72%40.64M

33.25%82.68M

-8.30%40.35M

-4.59%62.05M

-48.45%44.01M

-21.68%65.03M

13.86%85.36M

-16.53%83.03M

--74.98M

--99.47M

Non-current assets

Net Fixed Assets

-77.10%199.00K

-61.28%381.00K

-54.90%552.00K

-44.07%740.00K

-40.84%869.00K

-40.36%984.00K

--1.22M

--1.32M

--1.47M

--1.65M

-22.75%1.99M

-35.29%2.21M

-22.12%2.57M

59.15%3.42M

-76.26%3.30M

-85.97%2.15M

-16.30%13.92M

7965.83%15.32M

8183.30%16.63M

-8.31%190.00K

-8.41%200.74K

-3.39%207.22K

-12.94%219.16K

--214.48K

--251.74K

-Fixed Assets

-37.56%1.18M

--1.47M

-26.92%1.60M

-15.91%1.85M

-18.22%1.89M

----

--2.19M

--2.20M

--2.31M

--2.45M

-15.07%4.27M

-26.89%4.06M

0.97%5.03M

--5.56M

--4.98M

----

-Accumulated depreciation

-3.74%978.00K

--1.08M

8.61%1.05M

26.57%1.11M

21.53%1.02M

----

--964.00K

--877.00K

--836.00K

--800.00K

-7.00%2.28M

-13.42%1.85M

46.56%2.45M

--2.13M

--1.67M

----

Goodwill and other intangible assets

-31.23%381.00K

-19.75%516.00K

-19.52%643.00K

-45.73%470.00K

-43.00%554.00K

-40.96%643.00K

--799.00K

--866.00K

--972.00K

--1.09M

7.50%31.56M

-12.22%29.17M

-4.31%29.36M

-23.20%33.23M

-22.36%30.68M

-26.59%43.27M

-31.05%39.52M

41.59%58.94M

32.76%57.32M

-6.65%41.63M

28.41%43.17M

40.05%44.60M

-2.11%33.62M

--31.84M

--34.35M

Long-term debt

----

--0.00

----

Other non-current assets

----

--0.00

----

Total non-current assets

-59.24%580.00K

--897.00K

-40.93%1.20M

-44.72%1.21M

-41.70%1.42M

----

--2.02M

--2.19M

--2.44M

--2.74M

5.06%33.55M

-14.37%31.39M

-6.05%31.93M

-19.30%36.66M

-36.40%33.99M

-38.84%45.42M

-27.73%53.44M

77.60%74.27M

70.48%73.95M

-6.66%41.82M

28.17%43.37M

39.76%44.80M

-2.19%33.84M

--32.06M

--34.60M

Total assets

-40.56%40.61M

-39.89%45.92M

-39.60%53.60M

-34.85%62.63M

22.14%68.32M

14.87%76.39M

--88.75M

--96.13M

--55.94M

--66.50M

-22.12%102.44M

-37.70%106.55M

-34.36%131.53M

98.72%171.03M

47.21%200.38M

-24.91%86.07M

0.09%136.12M

33.56%114.62M

25.45%135.99M

-34.07%85.82M

-7.24%108.41M

21.62%130.17M

-12.83%116.87M

--107.03M

--134.07M

Liabilities

Current liabilities

-Other payables

1.23%905.00K

-32.33%741.00K

-60.33%622.00K

-57.61%777.00K

24.51%894.00K

7.25%1.09M

--1.57M

--1.83M

--718.00K

--1.02M

-81.51%1.76M

-48.21%889.13K

359.41%9.52M

--1.72M

--2.07M

----

Accrued expenses

-31.37%1.95M

-51.04%1.99M

16.16%3.84M

30.40%4.85M

12.13%2.85M

-19.94%4.07M

--3.30M

--3.72M

--2.54M

--5.08M

-1.85%6.08M

4.96%5.43M

6.52%6.19M

-9.39%5.18M

73.66%5.82M

-16.15%5.71M

-55.74%3.35M

20.35%6.81M

77.74%7.57M

-4.35%5.66M

--4.26M

--5.92M

----

Current provisions

----

66.56%5.97M

53.82%5.83M

106.46%3.59M

563.52%3.79M

4418.27%1.74M

39.50%571.53K

-90.92%38.44K

-3.27%409.71K

9.41%423.38K

14.40%423.55K

--386.97K

--370.23K

----

Short-term debt and lease liabilities

----

-100.00%0.00

--5.54M

--5.55M

--4.93M

--4.63M

--0.00

-70.50%5.94M

1560.50%13.97M

1910.59%20.13M

-3.23%841.51K

-94.29%1.00M

-96.30%869.60K

72.50%17.54M

169.42%23.50M

36.41%10.17M

232.81%8.72M

--7.45M

--2.62M

----

-Short-term lease liabilities

----

-12.21%619.96K

-33.01%563.72K

-29.46%706.15K

-3.23%841.51K

-9.59%1.00M

-74.64%869.60K

--1.11M

--3.43M

----

Deferred liabilities

----

-100.00%0.00

--0.00

--469.37K

----

Other current liabilities

1.23%905.00K

-32.33%741.00K

-60.33%622.00K

-57.61%777.00K

24.51%894.00K

7.25%1.09M

--1.57M

--1.83M

--718.00K

--1.02M

-41.00%7.73M

22.02%6.72M

244.09%13.11M

863.91%5.51M

9810.71%3.81M

-34.99%571.53K

-90.92%38.44K

107.55%879.08K

9.41%423.38K

14.40%423.55K

--386.97K

--370.23K

----

Total current liabilities

-17.61%6.18M

-68.93%4.30M

-57.66%6.02M

-51.14%7.56M

-31.87%7.50M

45.98%13.85M

--14.21M

--15.47M

--11.00M

--9.49M

-48.26%22.18M

75.94%29.85M

214.02%42.86M

44.88%16.97M

-50.78%13.65M

-70.44%11.71M

3.73%27.73M

91.96%39.62M

43.13%26.74M

58.81%20.64M

20.21%18.68M

228.27%13.00M

100.83%15.54M

--3.96M

--7.74M

Non-current liabilities

Long-term provisions

----

-69.12%522.14K

-100.00%0.00

212.00%1.69M

7.41%1.79M

-74.25%542.02K

-13.46%1.66M

-13.92%2.11M

-42.98%1.92M

-53.62%2.45M

-38.81%3.37M

122.95%5.27M

280.74%5.51M

61.19%2.37M

--1.45M

--1.47M

Long-term debt and lease liabilities

--0.00

-100.00%0.00

-80.98%1.01M

--394.00K

--552.00K

--727.00K

--5.30M

--4.66M

-100.00%0.00

-11.83%19.46M

37.86%24.80M

209.81%22.07M

20.89%17.99M

-61.87%7.12M

-26.19%14.88M

-26.49%18.68M

696.09%20.15M

559.07%25.42M

-35.65%2.53M

--3.86M

--3.93M

-Long-term debt

----

-100.00%0.00

--0.00

--4.39M

--4.66M

-100.00%0.00

-11.83%19.46M

37.86%24.80M

209.81%22.07M

20.89%17.99M

-61.87%7.12M

-26.19%14.88M

-26.49%18.68M

696.09%20.15M

559.07%25.42M

-35.65%2.53M

--3.86M

--3.93M

-Long-term lease liabilities

----

-100.00%0.00

11.26%1.01M

--394.00K

--552.00K

--727.00K

--906.00K

----

Other non-current liabilities

-48.52%383.00K

23.72%699.00K

-38.56%988.00K

-38.60%897.00K

-45.61%744.00K

-51.96%565.00K

--1.61M

--1.46M

--1.37M

--1.18M

-53.49%1.01M

-97.14%376.22K

-95.43%2.18M

-81.49%13.17M

2.54%47.68M

3205.29%71.17M

1575.17%46.49M

-54.15%2.15M

-61.98%2.78M

-35.90%4.70M

208.66%7.30M

406.54%7.33M

61.19%2.37M

--1.45M

--1.47M

Total non-current liabilities

-48.52%383.00K

--699.00K

-50.65%988.00K

-55.44%897.00K

-64.49%744.00K

----

--2.00M

--2.01M

--2.10M

--6.48M

74.82%6.90M

-94.70%1.85M

-94.75%3.95M

-63.08%35.01M

-4.03%75.17M

338.36%94.83M

128.16%78.33M

-7.48%21.63M

25.04%34.33M

-28.60%23.38M

460.66%27.46M

517.47%32.75M

-9.35%4.90M

--5.30M

--5.40M

Total liabilities

-20.40%6.56M

-67.57%5.00M

-56.79%7.00M

-51.63%8.45M

-37.09%8.24M

-3.39%15.42M

--16.21M

--17.48M

--13.10M

--15.96M

-37.87%29.08M

-38.99%31.71M

-47.29%46.81M

-51.22%51.97M

-16.26%88.82M

73.94%106.54M

73.68%106.06M

39.14%61.25M

32.36%61.07M

-3.76%44.02M

125.76%46.14M

393.86%45.74M

55.53%20.44M

--9.26M

--13.14M

Shareholders' equity

Common equity

1.24%554.16M

17969.86%552.76M

2.17%551.17M

2.18%549.46M

11.78%547.40M

-99.37%3.06M

--539.48M

--537.76M

--489.70M

--488.88M

9.45%366.09M

-8.09%309.90M

-8.28%334.47M

34.98%337.16M

61.56%364.65M

34.27%249.79M

27.78%225.71M

6.45%186.03M

-1.67%176.64M

9.20%174.76M

17.96%179.64M

29.51%160.04M

14.15%152.29M

--123.57M

--133.42M

Retained earnings

-7.52%-507.54M

-8.24%-501.02M

-8.30%-493.67M

-10.39%-486.64M

-10.14%-472.03M

-10.31%-462.88M

---455.84M

---440.84M

---428.58M

---419.63M

-15.58%-340.81M

-6.19%-240.11M

4.66%-294.88M

29.86%-226.12M

-26.78%-309.29M

-131.01%-322.37M

-122.10%-243.96M

1.65%-139.55M

13.53%-109.84M

-66.79%-141.88M

-127.41%-127.03M

-229.76%-85.07M

-347.49%-55.86M

---25.80M

---12.48M

Capital reserves

1.24%551.02M

--549.62M

2.17%548.04M

2.17%546.33M

11.78%544.27M

----

--536.43M

--534.73M

--486.93M

--486.11M

9.42%363.63M

-8.11%307.63M

-8.30%332.33M

34.78%334.79M

61.46%362.39M

33.80%248.40M

27.34%224.45M

7.65%185.64M

-0.56%176.27M

7.95%172.46M

16.61%177.26M

29.53%159.75M

14.16%152.01M

--123.33M

--133.16M

Less: Treasury stock

----

-100.00%0.00

--0.00

--1.23M

----

Gains losses not affecting retained earnings

17.78%-12.57M

-102.08%-10.82M

1.75%-10.91M

52.71%-8.64M

16.37%-15.29M

3078.51%520.79M

---11.10M

---18.28M

---17.48M

66.66%-858.79K

-468.74%-2.62M

-958.62%-2.58M

-124.94%-461.34K

-123.79%-243.36K

69.00%-205.09K

13.37%1.02M

---661.63K

--902.25K

----

Total equity

-43.32%34.05M

-32.89%40.92M

-35.76%46.60M

-31.12%54.18M

40.25%60.08M

20.64%60.97M

--72.54M

--78.65M

--42.84M

--50.54M

-13.41%73.36M

-37.14%74.84M

-24.06%84.72M

681.63%119.06M

271.15%111.56M

-138.35%-20.47M

-59.88%30.06M

27.68%53.38M

20.33%74.93M

-50.48%41.81M

-35.43%62.27M

-13.65%84.43M

-20.26%96.43M

--97.77M

--120.93M

Currency unit

--USD

Audit opinions

----

FAQs

Which balance sheet metrics matter most when analyzing MREO stock?



Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

What is the difference between assets, liabilities, and shareholders' equity?



Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

What is the difference between current and non-current items?



Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

How Much Cash Does Mereo BioPharma Group PLC Have?



In its most recent quarterly, Mereo BioPharma Group PLC had 36.22M in cash and cash equivalents.

How Much Are Mereo BioPharma Group PLC's Total Liabilities?



Mereo BioPharma Group PLC reported 5.00M in total liabilities as of the latest reported quarter, including 4.30M in current liabilities and 699.00K in non-current liabilities.

What Are Mereo BioPharma Group PLC's Total Assets?



As of the latest reported quarter, Mereo BioPharma Group PLC's total assets were 45.92M, consisting of 45.02M in current assets and 897.00K in non-current assets.

How Much Shareholders' Equity Does Mereo BioPharma Group PLC Have?



Mereo BioPharma Group PLC reported 40.92M in total shareholders' equity as of the latest reported quarter.